Noom said that it plans to offer a compounded ... The program also offers access to branded GLP-1 products, according to a statement. Novo Nordisk markets semaglutide for diabetes and weight ...

Digital health company Noom has launched a compound pharmacy-made version of Novo Nordisk's obesity drug semaglutide to make the drug more accessible to consumers in the US. The bold move has been ...

NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today unveiled two ...

As part of its commitment to employee well-being, the complex has chosen to incorporate Noom 50 chairs by ACTIU into its office environments. These chairs, renowned for their ergonomic design and ...

Products are chosen independently by our editors ... and Orange Dreamsicle—or get a monthly subscription for 10% savings.

Over the last 2 years, Noom has built the ultimate companion to a GLP-1 journey ahead of expected Prescription Drug Use-Related Software (PDURS) guidance finalization later this year.

Denmark’s Novo Nordisk has announced a tie-up with digital health firm Noom, focusing on helping people with obesity lose weight and keep it off. The weight management and education initiative ...